FDA Drug information
Rasuvo
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Rasuvo METHOTREXATE SODIUM 10 mg/.2mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 12.5 mg/.25mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 15 mg/.3mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 17.5 mg/.35mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 20 mg/.4mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 22.5 mg/.45mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 25 mg/.5mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 30 mg/.6mL Medexus Pharma Inc.
- Rasuvo METHOTREXATE SODIUM 7.5 mg/.15mL Medexus Pharma Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.